DZ Bank
ALXN

DZ Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

DZ Bank’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,033
Closed -$925K – 1022
2021
Q2 		$925K Hold
5,033
– – ﹤0.01% 700
2021
Q1 		$770K Sell
5,033
-240,576
-98% -$37.2M ﹤0.01% 662
2020
Q4 		$38.4M Sell
245,609
-180,031
-42% -$23.1M 0.08% 165
2020
Q3 		$48.7M Buy
425,640
+259,792
+157% +$28M 0.12% 131
2020
Q2 		$18.6M Buy
165,848
+142,597
+613% +$15.1M 0.05% 198
2020
Q1 		$2.09M Buy
23,251
+2,137
+10% +$210K 0.01% 435
2019
Q4 		$2.27M Buy
21,114
+5,629
+36% +$602K 0.01% 463
2019
Q3 		$1.52M Buy
15,485
+485
+3% +$54.7K ﹤0.01% 486
2019
Q2 		$1.97M Hold
15,000
– – 0.01% 484
2019
Q1 		$2.03M Buy
+15,000
New +$1.87M 0.01% 468
2018
Q2 		– Sell
-22,900
Closed -$2.55M – 1151
2018
Q1 		$2.55M Buy
22,900
+20,569
+882% +$2.46M 0.01% 512
2017
Q4 		$279K Sell
2,331
-1,569
-40% -$191K ﹤0.01% 690
2017
Q3 		$547K Buy
+3,900
New +$530K ﹤0.01% 631

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

DZ Bank's ALXN Position: Q3 2021 in Review

DZ Bank sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 5,033 shares — an estimated $925K sold.

DZ Bank first reported a position in ALXN in Q3 2017 and held it in 13 quarters. The position peaked at $48.7M in Q3 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • DZ Bank reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • DZ Bank sold 5,033 Alexion Pharmaceuticals shares in Q3 2021, an estimated $925K.
  • DZ Bank first reported a position in Alexion Pharmaceuticals in Q3 2017 and held it in 13 quarters.
  • DZ Bank's Alexion Pharmaceuticals position peaked at $48.7M in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on DZ Bank's 13F filing for Q3 2021, filed 15 Nov 2021.